To include your compound in the COVID-19 Resource Center, submit it here.

Herpes simplex 2 vaccine: Began two Phase III trials

Chiron Corp. (CHIR)
Product: Herpes simplex

Read the full 68 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE